From: Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients
No.
Start
End
Peptide
Length
1
6
17
RSYLTPGDSSSG
12
2
66
69
FTVE
4
3
73
82
YQTSNFRVQP
10
315
323
SNKKFLPFQ
9
5
341
342
TL
416
426
VNNSYECDIPI
11
7
717
Q
8
794
802
LGQSKRVDFC
942
E
944
945
DR